Speaker(s):

Bryan Chilson, PharmD candidate 2026, Geisinger - has nothing to disclose

Moderator(s): 

Michael M O’Hara RPh, Centralized Clinical Pharmacy Services, Geisinger - has nothing to disclose.

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

    1. Identify common agents that cause chemotherapy induced heart failure
    2. Determine treatment for chemotherapy induced heart failure

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Sarah F. Hale, PharmD, Daniel Longyhore, PharmD, Ed.D, BCACP, Michael M O’Hara RPh, and Mary Beth Mickel, CPhT have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPAA compliant. 

Commercial Support for this Session

None

Session date: 
11/18/2025 - 4:00pm to 4:30pm EST
Location: 
Virtual via Microsoft Teams
Danville, PA 17822
United States
  • 0.50 ACPE
  • 0.50 ACPE Tech
  • 0.50 Participation Credit
Please login or register to take this course.